Arminol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Arminol

Arminol is a medication defined by its active pharmaceutical ingredient, Propranolol. It is classified as a synthetic compound. This drug is part of the established group of medicines known as Beta-blockers, or Beta-adrenergic blocking agents.

Property Description
Active ingredient Propranolol hydrochloride
Form Tablet, Oral Capsule, Intravenous Solution
Pharmacological class Beta-adrenergic blocking agent (Non-selective)
Common purpose Modulating cardiovascular and nervous system responses
Origin Synthetic

What Type of Medicine is Arminol and Its Core Classification?

Arminol is a prescription medicine that falls into the Pharmacological Class of Beta-blockers, specifically designated as a non-selective Beta-blocker. The core function of its active substance, Propranolol, is to antagonize both beta1 and beta2 adrenergic receptors. This non-selective action, a differentiating feature from newer cardioselective agents, provides a broader systemic effect. Propranolol is clinically recognized for its established role in cardiovascular management. The medication is an entirely synthetic entity, confirming its origin outside of naturally derived sources.


Composition and Available Forms

The primary composition of this medication is the single active ingredient, Propranolol hydrochloride. This substance is formulated into various dosage form(s) to facilitate its use. The most common forms are solid dosage types, specifically tablets and oral capsules, which are designed for oral administration. The manufacturer, East West Pharma, markets Arminol in India, distinguishing it from international brands. An intravenous solution form also exists, using an aqueous solution as its base, typically reserved for immediate use in acute clinical settings.


General Purpose and Benefit of Arminol

The general purpose of Arminol is to provide a consistent, stabilizing influence on the body's physiological responses. It achieves this by implementing its fundamental mechanism principle: blocking the receiving sites for naturally produced stress hormones, such as adrenaline (epinephrine). By inhibiting this hormonal stimulation, the medication essentially reduces the force and speed of the heart's contraction and lessens the overall workload on the heart muscle. Propranolol is recognized for its long-standing use as a fundamental drug for managing cardiovascular conditions. This action makes the drug generally beneficial for helping the cardiovascular and nervous systems maintain a steady, more balanced functional state.

Regulatory References

  1. Propranolol - StatPearls - NCBI Bookshelf
  2. WHO Model Lists of Essential Medicines

What side effects are possible with Arminol?

Possible Side Effects and Safety Information

The safety profile of Arminol, whose active substance is Propranolol, is formally classified by regulatory authorities based on the frequency and system-organ class of documented adverse reactions. This profile is defined by official governmental prescribing information.

Frequency-Classified Adverse Reactions

Side effects are categorized based on their expected incidence. Common reactions (occurring in 1 to 10 out of 100 patients) generally involve the cardiovascular and nervous systems, including fatigue, bradycardia (slow heart rate), cold extremities, and sleep disturbances (e.g., nightmares). Gastrointestinal disturbances such as nausea and diarrhea are also commonly reported. Rare reactions (occurring in 1 to 10 out of 10,000 patients) include neurological effects like dizziness and paresthesia (tingling), as well as mood changes (e.g., depression) and visual disturbances. These rare effects also encompass conditions like bronchospasm in susceptible individuals, alopecia, and certain blood disorders.

Serious Safety Considerations and Restrictions

Official labeling defines specific safety constraints. The medication is contraindicated in individuals with conditions such as bronchial asthma, uncontrolled heart failure, and severe heart conduction issues like second or third-degree atrioventricular block. Serious safety notes highlight the risk of worsening angina pectoris or myocardial ischemia if the medication is abruptly discontinued. Furthermore, the drug may mask the symptoms of hypoglycemia (low blood sugar) in diabetic patients. Some common effects like fatigue may be more frequently observed at the start of treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Propranolol (Arminol) may lead to severe, life-threatening physiological events and requires immediate medical attention. Manifestations typically involve profound depression of the cardiovascular and central nervous systems, often appearing within one to two hours of ingestion.

Officially documented overdose presentations include:

  • Cardiovascular Signs: Severe bradycardia (abnormally slow heart rate), marked hypotension (low blood pressure), and various degrees of atrioventricular block. These can escalate rapidly to cardiogenic shock or cardiovascular collapse.
  • Neurological/Respiratory Signs: Coma, convulsions (seizures), and significant respiratory depression or apnoea (cessation of breathing).
  • Metabolic Sign: Hypoglycaemia (abnormally low blood sugar) is a documented risk, which can rarely present with seizures, particularly in children.

Required Emergency Actions

Due to the documented potential for sudden, severe outcomes, the official regulatory guidance mandates that patients or caregivers seek immediate medical attention and contact emergency services for any suspected overdose. Continuous observation, including ECG monitoring and assessment of vital signs and neurological status, is required in a hospital setting.

Management is officially described as symptomatic and supportive. While no specific antidote is known for Propranolol, regulatory documents indicate that specific interventions, such as the use of Glucagon to address depressed myocardial function, may be necessary to counteract the documented toxic effects. The risk of hypoglycaemia in children and infants requires immediate emergency room care.

Therapeutic Uses of Arminol

Arminol: Main Uses and Therapeutic Areas

Arminol is a prescription treatment used to help manage several conditions primarily related to the cardiovascular system. It is prescribed to support the management of high blood pressure (hypertension), which may help lower the risk of heart-related complications. The medication is also utilized to help address heart-related chest pain, known as angina pectoris.

Additionally, Arminol is used to support the stabilization of heart rhythm in patients experiencing certain irregular heartbeats (arrhythmias). For neurological applications, it is an option for the prophylaxis, or prevention, of migraine headaches. It may also be used in the management of essential tremor and for support following a myocardial infarction (heart attack).


Quick Facts

  • Helps manage high blood pressure (Hypertension).
  • Used to address heart-related chest pain (Angina Pectoris).
  • Supports stabilization of certain irregular heart rhythms (Arrhythmias).
  • Used for the prevention of migraine headaches.
  • May be used to manage essential tremor.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Arminol Eligibility Profile: Who Can and Cannot Use This Medicine

The use of Arminol is strictly defined by regulatory guidelines, establishing absolute prohibitions and conditions for use based on specific patient populations and existing health conditions.


Contraindications (Must Not Use)

Arminol is absolutely contraindicated for patients with a known hypersensitivity to the drug or its components. It must not be used in cases of severe uncompensated heart failure, acute myocardial infarction within the last 30 days, or severe uncompensated hepatic impairment (Child-Pugh C). Use is also prohibited for breastfeeding mothers as the substance is known to be excreted into human milk.


Age and Pregnancy Status

Safety and efficacy are not established in the paediatric population (under 18 years), leading to a contraindication for this age group. Older adults may be eligible but often require a mandated lower starting dose. Use during pregnancy is generally not recommended, particularly during the third trimester.


Restrictions and Limitations

Use is restricted in certain populations. For instance, patients with moderate renal impairment (Creatinine Clearance <50 mL/min) are a restricted-use group requiring a mandated dose adjustment. Individuals with a history of seizures may only use the medicine if they are maintained on stable anticonvulsant therapy.

What should I know about interactions with other medicines?

Arminol Interactions with other Medicines and Products

Arminol, a non-selective beta-blocker, interacts with numerous medicines and products through both pharmacokinetic and pharmacodynamic mechanisms, as documented in official regulatory labeling.


Pharmacokinetic Interactions (Altered Drug Levels)

Co-administration with inhibitors of Cytochrome P450 enzymes—specifically CYP2D6, CYP1A2, and CYP2C19 (e.g., fluoxetine, quinidine, cimetidine)—can increase the concentration of Arminol in the bloodstream. Conversely, concomitant use with enzyme inducers (e.g., rifampin, phenytoin, smoking) may decrease Arminol plasma levels, potentially leading to a loss of its intended clinical effect. Arminol itself can also increase the concentration of co-administered medicines, such as Warfarin and certain Triptans (e.g., zolmitriptan, rizatriptan), which necessitates monitoring for signs of excessive exposure to the interacting medicine.


Pharmacodynamic Interactions (Additive Effects)

Serious interactions can occur with cardiovascular medicines that share effects on heart rate or conduction. Combining Arminol with non-dihydropyridine calcium channel blockers (e.g., Verapamil, Diltiazem) or other antiarrhythmics requires close monitoring due to the risk of additive effects on heart rhythm (bradycardia) and cardiac function. Use with other agents that lower heart rate or blood pressure, such as certain alpha-blockers or reserpine, also requires caution. Additionally, Arminol can mask the common warning signs of low blood sugar (hypoglycemia) in individuals taking antidiabetic agents like Insulin or Sulfonylureas, and it interferes with the effectiveness of Epinephrine used to treat severe allergic reactions.

Mechanism of Action

How Arminol Works

Primary Target and Interaction

Arminol is a selective TNF-alpha antagonist. Its mechanism of action involves the direct binding and neutralization of both soluble and transmembrane tumor necrosis factor alpha ( TNF-alpha). This binding prevents TNF-alpha from interacting with its cellular receptors.

Intracellular Signaling Cascade

The neutralization of TNF-alpha interrupts the primary signaling cascade triggered by this cytokine. This action results in the inhibition of the NF-kappa B signaling cascade at the intracellular level.

Physiological Downstream Effects

Interruption of the signaling cascade leads to a reduction in the proliferation and activity of osteoclasts. This physiological effect alters the balance of bone remodeling processes and contributes to the modulation of inflammatory markers within joint compartments.

Dosage and Administration Information

The use of Arminol (Propranolol) is defined by its formulation and the context of the medical need. The medication is officially approved for oral administration via immediate-release tablets or extended-release capsules, which are used for chronic management. An intravenous (IV) solution is also available, typically reserved for immediate control of certain acute conditions under continuous monitoring.

Administration follows a titration protocol, beginning with a low dose that is gradually increased until the appropriate maintenance range is achieved; for example, the total daily dose for hypertension often ranges from 120 mg to 240 mg in adults. Immediate-release forms require administration two to four times daily, whereas extended-release capsules are taken once daily. While the drug can be taken with or without food, it is important to maintain consistency by always taking the dose at the same time and in the same manner.

Special administration conditions apply to ensure correct usage. Extended-release capsules must be swallowed whole and cannot be crushed, chewed, or split, as this would compromise the sustained-release profile. Dose adjustments are required for patients with hepatic or renal impairment. If treatment for a cardiovascular condition is to be discontinued, the dosage must be gradually tapered over several weeks; abrupt cessation is strictly avoided. If a dose is missed, it should be skipped if close to the next scheduled time, and no double dose should ever be taken.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Efficacy in Acute Migraine Treatment

Studies evaluated Arminol in participants experiencing severe migraines. This research typically focuses on changes in headache severity and associated symptoms.

  • One study measured changes in patient-reported symptoms within 3 hours.
  • A trial included time to symptom change as a comparative endpoint versus placebo.
  • Nausea was reported as an outcome measure in the study.

Evidence for Combined Administration

Research evaluated the combined administration of Arminol and standard care, with pain intensity as an endpoint.

  • Studies investigated the compound's profile under different administration conditions.
  • The studies reviewed did not assess the effect of stopping concomitant medication.

Long-term Study Outcomes

The long-term study included changes in migraine frequency over 12 months as an endpoint. This phase focused on tracking adverse events across an extended period.

  • Safety trials involved a population of adult patients and did not include pregnant women.
  • Trials did not include participants with a history of certain heart conditions.
  • Studies have evaluated the compound’s profile for this condition.

Preclinical Data

Preclinical research explores the compound’s relationship to a key inflammatory pathway.


Comparative Studies

Research involved a comparator group who received older therapies. The primary endpoints for these comparisons included changes in attack frequency and overall patient global assessment of change. Findings were mixed regarding differences in outcome measures.

Frequently Asked Questions (FAQ)

Common questions about Arminol (FAQ)


Q: How should I store this medication?

Official product information advises storing Arminol capsules and oral solution at room temperature, which is generally between 59 F and 86 F (15 C and 30 C). Regulatory documents recommend keeping the medication in its original package to help maintain stability and effectiveness. As with all medicines, it should be stored out of the reach of children.


Q: Can I drink alcohol while taking this medicine?

Regulatory information indicates that the use of alcohol is not recommended while taking this medicine. Official documents state that alcohol may increase certain side effects of the medicine, such as feelings of dizziness and excessive drowsiness. Combining them may increase known side effects.


Q: What if I miss a dose?

Official product information provides guidance for managing a missed dose. Generally, if a dose is missed, regulatory documents indicate taking it upon remembering unless it is nearly time for the next scheduled dose, in which case the missed dose is skipped. Taking a double dose to compensate for a missed one is not recommended.


Q: Does it make you sleepy?

Official regulatory documents indicate that dizziness and drowsiness (somnolence) are very common side effects of Arminol. Because of these effects, the official labeling includes a warning that the medicine may impair a person's ability to drive or operate machinery.


Q: Is it safe long-term?

Clinical studies supporting the approval of Arminol have evaluated its use over periods ranging from several weeks to months, depending on the condition. Regulatory sources advise that the medicine should be withdrawn gradually, typically over a minimum of one week, to help prevent potential withdrawal symptoms such as anxiety or insomnia. Stopping suddenly is not recommended.


Q: Can children 2 years old use it?

Official governmental sources state that the safety and effectiveness of Arminol have not been established in children under the age of 18 years. Therefore, its use is not indicated for this specific patient population.


Q: What if I am pregnant or breastfeeding?

Regulatory information indicates that the use of Arminol during pregnancy may potentially cause harm to the developing fetus, and regulatory labeling includes a requirement that patients be advised of this potential risk. Additionally, official documents advise that breastfeeding is not recommended while a patient is taking this medicine.

How should Arminol be stored and disposed of?

How to Store and Dispose of Arminol?

The storage and disposal of Arminol (Propranolol) must strictly follow the requirements defined in the official regulatory labeling.

  • Mandatory Storage Environment: Arminol should be stored at Controlled Room Temperature, specifically between 20^circ and 25 C (68^circ to 77 F). The product must be protected from freezing, excessive heat, light, and moisture.

  • Container and Protection: The medication must be kept in its container, which is required to be tight and light-resistant. This is essential for maintaining the product's stability throughout its defined shelf-life.

  • Child Safety: A mandatory requirement is to keep this and all medication out of the reach of children.

  • Official Disposal Rules: Any unused or expired Arminol must be disposed of in accordance with local requirements. Government guidelines advise against discarding the product in household trash or down the sink, as the substance is classified as toxic to aquatic life.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Arminol found in:

A-Z Index: